For years, a lot of investors thought about cybersecurity in pretty simple terms…

Big targets got attacked. Banks, defense contractors, federal agencies, hospitals, maybe the occasional retailer with millions of customer records.

The average person? The local business owner? The consultant with a Gmail inbox and a half-dozen cloud logins? They didn’t feel like the main event.

But that way of thinking is getting old fast…

When The Targeting Gets “Personal”

Last week’s reported breach of FBI Director Kash Patel’s personal email account is a perfect example.

According to Reuters and the Associated Press, an Iran-linked group known as the Handala Hack Team claimed responsibility for accessing Patel’s personal Gmail account and publishing old emails, photographs, and other personal documents online.

Now, the FBI already said the exposed material was historical and didn’t involve government information.

In other words, this wasn’t a compromise of the FBI’s internal systems. It was a compromise of a person.

But that’s exactly why it matters…

The story here isn’t that some explosive government secret was exposed.

The story is that high-value individuals are increasingly targets in their own right.

State-backed hackers, politically motivated operators, cybercriminals, and hybrid threat groups aren’t just storming the front gate anymore.

They’re checking side doors, windows, private accounts, old cloud storage, personal devices, and the messy overlap between work life and home life.

That should get investors thinking, because once the threat moves from institutions to people, the addressable market for cybersecurity gets a whole lot bigger.

Why The New Perimeter Is You

Here’s the thing a lot of people still don’t fully appreciate…

The old cybersecurity model was built around the office.

Secure the company network. Lock down the servers. Put controls around the data center. Train employees not to click suspicious links and call it a day.

But that world is gone.

Now we live in a world of remote work, personal devices, shared drives, cloud apps, password reuse, online banking, digital identities, home Wi-Fi, smart devices, and constant account creation.

People don’t have one digital footprint anymore. They have dozens of them, sometimes hundreds.

And every one of those accounts, apps, subscriptions, and connected devices adds another potential entry point.

For a small business, that sprawl is even worse…

Many small and midsize businesses still don’t have formal cybersecurity maturity.

NIST’s Small Business Quick-Start Guide is aimed specifically at organizations with “modest or no cybersecurity plans in place,” which tells you plenty about the state of the market right there.

NIST also frames cybersecurity as a core risk-management issue, not an optional IT upgrade.

And that’s where the opportunity lies hidden in plain sight…

If the biggest institutions in the world still struggle to stay ahead of cyber threats, imagine how exposed the average dentist office, local manufacturer, real estate firm, wealth manager, or e-commerce startup really is.

These are businesses that often run on thin budgets, fragmented software, outsourced IT, and overworked employees who are one convincing email away from big trouble.

And on the individual side, the problem is just as obvious…

The FBI’s latest Internet Crime Report says the IC3 logged 859,532 complaints in 2024, with reported losses exceeding $16 billion, up 33% from the prior year.

The top complaint categories included phishing, extortion, and personal data breaches.

That’s not some niche risk buried in a technical white paper. That’s mainstream economic damage.

As AI Lowers the Barrier the Threat Surface Gets Wider

If this story ended with “cyber threats are growing,” that would already be enough to justify a bullish view on the industry. But there’s another layer here, and it’s a big one…

Artificial intelligence is making cyber offense more scalable.

Microsoft said in its 2025 Digital Defense Report that nation-state actors rapidly adopted AI to make operations more advanced, targeted, and scalable.

Google’s Threat Intelligence team reported in early 2026 that threat actors were increasingly integrating AI to accelerate reconnaissance, social engineering, and malware development.

That doesn’t mean every hacker is now some sci-fi supervillain. But it does mean the tools are getting better, faster, cheaper, and easier to use.

And that matters because one of the historic limits on cybercrime was labor…

Bad actors still needed time, skill, and coordination.

AI helps them write better phishing messages, research targets faster, generate believable fake content, automate portions of code development, and refine social engineering campaigns at scale.

And even modest gains in attacker productivity can create a huge headache for defenders when multiplied across millions of targets.

So now combine three things: more digital lives, more digital businesses, and more efficient attackers.

That is not a recipe for shrinking cybersecurity demand. It’s a recipe for decades of expansion.

What Starts with High Value Targets Rarely Ends There

A lot of major trends begin at the top before they flow downward…

Luxury goods. Financial products. New software tools.

Security is no different.

Today, a breach involving someone like the FBI director grabs headlines because of the symbolism.

It shows that even politically significant, security-conscious figures can still be hit through personal channels.

But markets shouldn’t read that as a one-off. They should read it as a signal…

When attackers discover that personal accounts, consumer-grade tools, and weakly secured side channels offer access, embarrassment value, leverage, or disruption potential, they don’t keep that lesson in a vault.

They apply it more broadly.

That means executives, public officials, defense personnel, medical professionals, attorneys, investors, journalists, influencers, and small business owners all become more attractive targets.

Not because each person holds classified secrets, but because personal compromise is often useful enough…

Maybe it produces extortion material. Maybe it yields financial information.

Maybe it provides credential reuse into a work account.

Or maybe it just creates enough chaos to make the attack worth it.

Why Cybersecurity Still Looks Like a Growth Industry

And here’s where the investment case gets really interesting: the public is slowly waking up to this reality.

For years, cybersecurity spending could be sold as a corporate necessity. Going forward, it’s also likely to be sold as a personal necessity.

Identity protection, password security, dark web monitoring, endpoint protection, secure communications, managed detection, zero-trust access, cloud security, and AI-driven threat intelligence are no longer products meant only for Fortune 500 companies.

They are increasingly pieces of a much wider defense stack for businesses and individuals alike.

This is why I continue to see cybersecurity as more than just another tech subsector. It’s becoming foundational infrastructure.

National defense needs it. Corporate America needs it. Small businesses need it. Families need it.

And as awareness rises, the market is likely to keep broadening from elite enterprise budgets into mass-market services and mid-market protection layers.

That’s a powerful setup for investors because cybersecurity isn’t being pushed by one flashy theme. It’s being pushed by multiple forces at once…

Digital dependence keeps growing. Threats keep evolving. Regulators keep paying attention.

Criminal losses keep rising as state-backed actors keep testing new pressure points.

And now AI is helping both defenders and attackers move faster, which only raises the urgency around the tools that can keep up.

In other words, this isn’t a fad market. It’s a necessity market.

And necessity markets can get very large.

The companies that help secure identities, devices, email, cloud workloads, networks, endpoints, payments, and personal digital lives are playing into a trend that still looks underappreciated by the broader public.

Most people still think cybersecurity is something they’ll deal with after something bad happens. And most small businesses still act like they’re too small to matter.

That complacency is exactly what expands the runway for the industry.

Before The Crowd Figures It Out

The Patel email breach may not have exposed government secrets, but it exposed something else…

The myth that cybersecurity is mostly about protecting giant institutions from giant attacks.

It’s about protecting people now too. Important people, ordinary people, business owners, employees, families, and anyone else living an increasingly digital life.

That’s why this industry still has lots of room to run.

The threats are getting smarter. The attack surface is getting wider. The public is getting more aware. And the spending response, in my view, is still in the early innings.

That should matter to investors…

Because by the time the crowd fully realizes cybersecurity isn’t optional anymore, a lot of the best opportunities may already be well on their way.

So, learn more about the threats and the growing market defending against them.

Study the companies building the tools that protect governments, corporations, small businesses, and individuals in this new threat environment.

And if you believe the digital world is only getting bigger, more connected, and more vulnerable, then don’t wait around for the crowd to bless the trade.

Get invested today, before they figure it out.

SpaceX has confidentially filed for an IPO with the SEC, setting up what could be the largest stock-market debut in history as early as June 2026.

What SpaceX filed today

SpaceX submitted a draft registration statement to the SEC using the confidential IPO process, which allows regulators to review and comment on the filing before any financials are made public.

Under current rules, the company must publish its S‑1 at least 15 days before it begins its roadshow, so detailed numbers should hit the tape sometime in April or early May if the June timetable holds.

Bloomberg and others report the deal is internally codenamed “Project Apex,” underscoring expectations that this will be the marquee equity event of 2026.

The offering is expected to list in the U.S., with prior reports pointing to Nasdaq as the likely venue, though the company has not yet confirmed an exchange or ticker.

SpaceX has reportedly lined up an unusually large syndicate of around 21 banks to manage the IPO, a sign of both the expected scale of the deal and the scramble on Wall Street to secure economics on a once‑in‑a‑decade transaction.

Size, valuation and records in play

Multiple outlets peg SpaceX’s target valuation around $1.5–1.75 trillion at IPO, which would place it behind only a handful of mega‑caps like Apple, Microsoft, Alphabet, Amazon and Nvidia on day one.

At that level, SpaceX would debut above the market value Saudi Aramco achieved in its record 2019 listing and on par with or above the valuation range previously discussed in late‑2025 IPO planning leaks.

On proceeds, media reports suggest the company could raise up to $75 billion dollars in a combination of primary and secondary stock, more than triple the current U.S. IPO record and far ahead of Saudi Aramco’s roughly $29 billion take.

Analysts note that even a more modest raise would still drain a substantial amount of liquidity out of the broader growth and tech complex for a time, as both institutions and retail carve out room for the deal.

SpaceX IPO context vs peers

What’s driving the story

Media coverage emphasizes SpaceX’s dual identity as both a launch provider and a global communications and AI infrastructure play, thanks largely to Starlink and the recent integration of Musk’s xAI into the company.

Starlink is already generating meaningful cash flow, and commentators frame SpaceX less like a traditional aerospace contractor and more like a vertically integrated infrastructure and data utility with a space transportation arm attached.

Recent analysis also highlights that SpaceX benefits from quasi‑critical‑infrastructure status: its launch and satellite networks are embedded in defense, government, and commercial connectivity contracts worldwide.

That positioning, some strategists argue, insulates the company from the consumer‑cyclical dynamics that drive sentiment around Tesla and other Musk‑linked assets, even if his public persona remains polarizing.

Early takeaways from investing media

  • – “Generational” but not cheap: Commentators describe the deal as a “generational” opportunity to buy the dominant space platform, while warning that traditional valuation frameworks will be stretched or broken at a 1.5–1.75 trillion dollar market cap. Several outlets frame the IPO more like buying into a long‑duration infrastructure and data monopoly than a conventional industrial business, with correspondingly high execution and regulatory risk.reddit+3
  • – Liquidity gravity well: Coverage on CNBC and Reuters stresses that a 50–75 billion dollar raise will likely siphon capital away from other high‑growth names, including Tesla, newer space entrants, and 2026 AI listings such as OpenAI and Anthropic. Some analysts explicitly warn of “crowding out” effects as investors rotate from secondary names in space and AI into SpaceX’s perceived blue‑chip growth story.finance.yahoo+4
  • – Retail access and hype cycle: Reports that as much as roughly 20 percent of the float could be reserved for retail and existing customers have fueled expectations of a heavily oversubscribed deal and a volatile day‑one trading profile. Media commentary repeatedly draws comparisons to the Tesla and dot‑com manias, noting that enthusiasm may front‑load returns and raise the odds of a sharp post‑IPO shakeout if fundamentals or launch milestones stumble.finance.yahoo+4
  • – Musk risk is real but different: Opinion pieces argue that while Musk‑related headline risk will matter, SpaceX’s dependence on government and enterprise contracts, along with the strategic nature of its assets, reduces the chance that controversy alone derails the business. Analysts still flag governance, concentration of control, and key‑person risk as central parts of any investment thesis, especially now that Musk will be running multiple massive public companies at once.cnbc+2

For now, the market is treating today’s filing less as a surprise and more as a catalyst that turns years of rumor into a defined timeline, with investors already positioning around what could be the defining IPO of this cycle.

If you can’t wait for the IPO to get exposure to the “space tech” economy, check out this article with more “moonshot” investment ideas.

Click Here

NASA really is lighting the candle on April Fools’ Day – and no, this isn’t a meme or a prank. Humanity is actually going back to the moon tonight, and it’s being live streamed by NASA.

NASA’s Live Artemis II Feed

The Artemis II mission is a roughly 10‑day loop around the moon and back, designed to prove that Orion capsule can keep a crew alive and talking in deep space, then survive the violent re‑entry back through Earth’s atmosphere.

If it works, NASA can move ahead with Artemis III, the mission that aims to put humans back on the lunar surface.

Unlike Apollo, which was largely about planting a flag, Artemis is explicitly about building repeatable infrastructure: transport, landers, power, communications and long‑term operations in cislunar space.

That shift creates a multi‑year spending pipeline, with NASA and the Pentagon anchoring demand and a growing roster of for‑profit companies doing the heavy lifting ….

And, of course, whenever Uncle Sam opens the ol’ checkbook … potentially billions of dollars start flowing toward investors who are well positioned. .

With that in mind, here are three ways to play Space Race 2.0 …

Mega Cap: SpaceX

SpaceX sits at the center of almost every serious conversation about launch, satellite broadband, and deep‑space logistics.

Recent reporting suggests the company is weighing a 2026 IPO that could value it around $1.5–1.75 trillion, with tens of billions raised in what would likely be the largest stock market listing in history by proceeds.

Those numbers rest on a business that already generates double‑digit billions in annual revenue, driven by the Falcon launch business and Starlink’s fast‑growing broadband network.

But access is the problem.

SpaceX remains private, and most investors cannot buy its shares directly.

One of the few liquid ways to get indirect exposure is through the ERShares Private–Public Crossover ETF, ticker XOVR.

The fund holds a mix of public growth equities, but it also has a dedicated private‑equity sleeve, and SpaceX is the dominant position in that private bucket.

Filings and third‑party analysis indicate that XOVR’s SpaceX stake has accounted for a high‑single‑digit to low‑double‑digit percentage of fund assets, at times climbing higher as valuation marks are updated.

For an investor building a diversified “space tech” portfolio, XOVR is one of the few ways the average investor can get SpaceX exposure before its IPO.

The trade‑off is that you’re accepting valuation risk on a private company and active‑manager risk on the public holdings in exchange for a seat at the table if the rumored record‑breaking IPO materializes.

Mid-Cap: Rocket Lab (RKLB)

Step down from the mega‑cap narrative and you reach Rocket Lab, one of the only publicly traded companies that regularly builds and launches rockets while also selling satellites and mission hardware.

Its Electron rocket has become a frequent small‑sat launch vehicle, and the company is developing Neutron, a larger medium‑lift system aimed at higher‑value missions.

Rocket Lab’s business is split between launch services and a “space systems” segment that provides spacecraft, components and mission services to government and commercial customers.

In 2025, the company reported roughly $602 million in revenue, up about 38% percent year‑over‑year, with guidance pointing to continued strong growth into 2026.

The flip side is that Rocket Lab remains unprofitable on an adjusted basis, with management acknowledging ongoing losses as it invests in Neutron and national security capabilities.

In an Artemis‑driven world where more payloads are heading not just to low‑Earth orbit but eventually into lunar and cislunar trajectories, a mid‑cap like Rocket Lab offers direct operating leverage to launch cadence and satellite deployment.

It is not as diversified or entrenched as SpaceX, and its smaller scale means higher volatility, but for a diversified “space tech” portfolio structure, it fits neatly as the growth engine sitting just below the mega‑cap anchor.

Small Cap: Redwire (RDW)

At the small‑cap end of the spectrum, infrastructure becomes the story.

Redwire does not operate rockets; it builds the critical hardware that rides on them and supports missions once in space.

Its offerings include deployable structures, power systems, avionics and in‑space manufacturing technologies used across NASA exploration initiatives, defense payloads and commercial satellites.

Financially, Redwire has been moving from an acquisition‑driven roll‑up toward a more coherent operator.

The company reported about $335.4 million in revenue for 2025, a year‑over‑year increase of just over 10%, with fourth‑quarter growth exceeding 50% as new contracts ramped.

Management cited a backlog around $411 million and a book‑to‑bill ratio above one, supporting guidance for 2026 revenue in the $450–500 million range. Its market capitalization, in the ballpark of $1.6–1.8 billion dollars, keeps it firmly in small‑cap territory.

Because Redwire sells into multiple end‑markets—NASA exploration, national security, and commercial operators—it offers a way to bet on the build‑out of space infrastructure without tying everything to a single launch platform.

The risks are what you’d expect from a small contractor: execution on integration, sensitivity to government budgets, and meaningful share‑price volatility.

In “risk and reward” framing, Redwire is squarely in the high-risk, high-potential-reward category: a high‑beta complement sized appropriately within a broader allocation.

Wild Card: Starfighters Space (FJET)

If you want a genuine “swing for the fences” name to round out this space basket, Starfighters Space (FJET) is about as pure a “space tech” play as it gets – and in a good way.

The company operates out of Kennedy Space Center with a fleet of modified F‑104 supersonic aircraft capable of sustained Mach 2, and it’s positioning those jets as reusable air‑launch and high‑speed test platforms rather than museum pieces.

The vision is straightforward but differentiated: use proven, piloted aircraft to carry payloads to high altitude, then air‑launch small rockets or test vehicles, while also selling high‑speed flight, hypersonic R&D, and training services to defense and commercial customers.

That gives FJET something many tiny space names lack: a tangible, already‑flying asset base and a business model that lines up cleanly with where defense and space spending are headed.

If the company can keep turning technical credibility at Kennedy into more contracts with prime contractors, government programs, and commercial partners, the operational leverage from a relatively fixed fleet and growing utilization could be powerful.

In an Artemis‑era “new space” portfolio, this is the name that could surprise to the upside if management executes and the market starts to price in a real niche around hypersonic testing and air‑launch.

Putting Artemis in a Portfolio Context

On launch night, it’s easy to focus on the euphoria of the launch: the countdown, the ignition, the voice over the loop calling “liftoff.”

And, at the risk of editorializing, you absolutely should get pumped up.

Artemis II deserves that attention — it is, in fact, historic.

But the bigger story for investors is that this mission is part of a deliberate shift toward sustained human activity beyond low‑Earth orbit, with implications that stretch across launch, satellite networks, defense and industrial infrastructure.

The April Fools’ timing makes for an easy headline, but the underlying trend is anything but a joke. The question is less whether capital will flow into space over the next decade, and more how you want your own exposure to ride along.

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of Starfighters Space, Inc. (NYSE: FJET). The Investment Journal is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities. In an effort to enhance public awareness, Starfighters Space, Inc. (NYSE: FJET) is the sole source of funds for a budget of approximately $917,500 provided to the advertising agency to cover the costs associated with creating, printing and distribution of this advertisement. The Investment Journal may receive subscription revenue in the future from new subscribers as a result of this advertisement for its newsletter. The advertising agency will retain any excess sums after all expenses are paid. Readers should beware that the advertising agency and/or its owners ,officers, principals, or affiliates own shares and/or stock options of Starfighters Space, Inc. (NYSE: FJET) and therefore have an additional incentive to see the company’s stock perform well. This share ownership should be viewed as a major conflict with our ability to be unbiased. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. While this advertisement is being disseminated and for a period of not less than 90 days thereafter, The Investment Journal, the advertising agency, and their respective officers, principals, or affiliates will not sell securities of Starfighters Space, Inc. (NYSE: FJET). If successful, this advertisement will increase investor and market awareness of Starfighters Space, Inc. (NYSE: FJET) and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, the advertising agency and The Investment Journal do not purport to provide a complete analysis of Starfighters Space, Inc. (NYSE: FJET) or its financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about Starfighters Space, Inc. (NYSE: FJET). Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in Starfighters Space, Inc. (NYSE: FJET) SEC filings. Investing in microcap securities such as Starfighters Space, Inc. (NYSE: FJET) is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agency and The Investment Journal cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains forward-looking statements, including statements regarding expected continual growth of Starfighters Space, Inc. (NYSE: FJET) and/or its industry. The advertising agency and The Investment Journal note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect Starfighters Space, Inc. (NYSE: FJET) actual results of operations. Factors that could cause actual results to vary include the size and growth of the market Starfighters Space, Inc. (NYSE: FJET) products and/or services, the company’s ability to fund its capital requirements in the near term and long term, federal and state regulatory issues, pricing pressures, etc. The Investment Journal is the publisher’s trademark. All trademarks used in this advertisement other than The Investment Journal are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agency and The Investment Journal are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks.

When war breaks out, the market usually runs to the usual suspects first.

Missile makers. Drone companies. Radar systems. Ammunition manufacturers. The old-line defense contractors that everybody can recognize without even opening a 10-K.

And to be fair, that trade makes sense… 

As the conflict with Iran escalated this month, investors quickly recognized that military spending, replenishment orders, and national-security urgency would be a gift to the traditional defense complex. 

And at the same time, broader markets wobbled under the pressure of oil shocks, inflation fears, and geopolitical uncertainty. 

But while the market was staring at tanks, drones, and interceptors, another battlefield was expanding right under its nose.

The Obvious Winners Aren’t the Only Winners

That battlefield was digital.

Reuters reported in early March that U.S. banks had already gone on heightened alert for potential Iran-linked cyberattacks as the war escalated, with industry groups and executives emphasizing operational resilience across critical financial infrastructure. 

Intelligence assessments cited by Reuters said Iran-aligned hacktivists could launch low-level cyberattacks against U.S. networks, and advisers flagged Iran’s willingness to target commercial systems, including financial ones. 

That tells us this is not a niche side story. It’s not just a Pentagon issue. It’s not just a “government IT” issue. To be fair, it’s not even just a banking issue.

It’s an everything issue…

War No Longer Stays on the Battlefield

One of the great mistakes investors keep making is imagining war in twentieth-century terms while living in a twenty-first-century world.

They still think war is mostly about ships, planes, bombs, and boots. And those things still matter, of course. 

But modern conflict spills into payment systems, hospital networks, supply chains, cloud architecture, executive communications, industrial controls, and surveillance networks. 

In other words, it spills into the plumbing of modern life.

The Justice Department announced on March 19 that it had seized four domains tied to Iran’s Ministry of Intelligence and Security..

Those sites were used to support hacking efforts, psychological operations, stolen-data publication, and even calls for the killing of journalists and dissidents. 

That’s not just cybercrime. That is cyberwar blended with intimidation, propaganda, and transnational pressure. 

And the public-sector warnings have been piling up, too… 

CISA’s Iran threat advisory says U.S. critical infrastructure and other U.S. entities should remain vigilant for targeted cyber activity by Iranian-affiliated actors.

And FINRA has warned firms about heightened threats from Iranian cyber actors amid the current Middle East tensions. 

This is what markets periodically forget: when the geopolitical temperature rises, hackers don’t need aircraft carriers to make themselves felt. 

They need access, automation, patience, and a vulnerable target. And that target can be a federal agency or military base. 

But it can also be a hospital, a manufacturer, a bank, a logistics company, an energy operator, or a wealthy executive with information that looks interesting to the wrong people.

AI Didn’t Eliminate Cyber Risk. It Supercharged It

Now let’s talk about the part that makes last month’s cybersecurity selloff look so silly.

In late February, shares of cybersecurity companies including CrowdStrike, Datadog, and Zscaler fell around 11% in a single session after Anthropic launched a coding-security tool.

Fortinet, Okta, Palo Alto Networks, and SentinelOne also all plunged as investors worried AI tools would pressure the industry. 

The market was acting as though AI might flatten the moat around cybersecurity vendors and somehow automate away the need for them. 

That was always a shallow read.

AI doesn’t magically make vulnerabilities disappear. It accelerates both sides of the contest. 

Yes, it helps defenders move faster, but it also helps attackers scan, probe, craft lures, exploit weaknesses, and sift through stolen data at machine speed.

Zscaler’s 2026 AI Threat Report says enterprise AI systems could often be compromised in as little as 16 minutes, found critical flaws in 100% of systems analyzed, and reported that data transfers to AI and machine-learning applications surged 93% to more than 18,000 terabytes. 

In plain English, AI is expanding the attack surface even as it becomes part of the defense stack. 

Palo Alto Networks put it even more bluntly in its 2026 outlook, arguing that 2026 would be the “Year of the Defender,” with AI-driven defenses needed to counter attackers who are using AI to scale and accelerate threats. 

That’s the real story. AI is not replacing cybersecurity. 

AI is making cybersecurity more necessary, more complex, and more central to national and corporate survival.

The Camera Is Now a Weapon

If investors needed a more vivid example, they got one…

Associated Press reported this week that hacked surveillance systems played a role in Israel’s targeting of Iran’s leadership, with advances in AI allowing intelligence services to sift through huge amounts of camera footage and identify targets far faster than human teams could. 

The AP report also noted that experts have long warned that internet-connected cameras could be hacked and weaponized, and that AI now makes automated target identification vastly more feasible in real time. 

Pause there for a second.

A camera used to be a passive device. Now it can become an intelligence node. A security feed can become a targeting tool. A convenience product can become a wartime liability.

That is a massive theme, and it stretches far beyond Tehran.

Corporate campuses have cameras. Warehouses have cameras. Energy facilities have cameras. Private homes have cameras. Gated neighborhoods have cameras. 

Transportation hubs have cameras. Governments have cameras everywhere. 

The more connected the world becomes, the more surfaces there are to attack, hijack, spoof, or exploit.

And when AI can process those feeds at scale, the stakes get even higher.

That doesn’t shrink the cybersecurity market. It expands it.

Uncle Sam and Corporate America Need the Same Shield

Another reason the recent selloff looked unreasonable is that the demand base for cybersecurity isn’t narrow. It is broadening.

The federal government is leaning harder into AI-enabled cyber defense. 

Agencies and industry are exploring AI to strengthen cybersecurity as the administration’s cyber strategy places a premium on using AI to better secure federal networks. 

At the same time, government procurement is not theoretical. 

GSA announced a OneGov agreement with Palo Alto Networks covering AI security, cloud security, next-generation firewalls, and zero-trust access for federal infrastructure through January 2028. 

CrowdStrike said in March that it expanded GovCloud capabilities for public-sector agencies inside a FedRAMP High-authorized environment, explicitly positioning those tools to stop AI-accelerated threats. 

Zscaler continues to market zero-trust tools for the Department of Defense, while SentinelOne highlights a FedRAMP-High platform for federal civilian agencies. 

That’s just the public side.

On the private side, reporting on the banking sector shows the same pattern: commercial firms don’t get to opt out of cyber conflict just because they don’t wear uniforms. 

Financial institutions, medical-device companies, and other enterprises are all in the blast radius when geopolitical actors start using digital channels to spread disruption. 

So, when investors think about cybersecurity now, they shouldn’t think of it as just another software bucket competing for budget with marketing tools and workflow apps. 

They should think of it as strategic infrastructure.

That’s an entirely different category. And categories like that tend to command better multiples over time than the market gives them during panic selloffs.

The Selloff Was a Story Problem, Not a Business Problem

Markets love neat stories…

Last month’s story was that AI would commoditize huge chunks of software, compress margins, and expose parts of cybersecurity as less special than investors thought.

Cute story. Bad conclusion.

Because the actual business backdrop moved in the opposite direction.

The Iran conflict increased the urgency around cyber readiness… 

Official warnings intensified. Law-enforcement actions accelerated. Private-sector vigilance rose. AI-related attack surfaces kept growing. 

And the examples coming out of the region showed that digital tools are now deeply embedded in modern conflict, intelligence, and retaliation. 

That doesn’t sound like an industry heading for irrelevance.

It sounds like an industry getting repriced by reality.

And that’s usually where opportunity lives.

Where Investors Should Start Looking

This is not a call to blindly buy every stock with the word “cyber” in its investor presentation. 

Plenty of companies will overpromise. Some will get out-innovated. Some will spend years proving they can turn technological relevance into durable profits.

But the broad theme is getting harder to ignore…

Investors who want to understand this space better should be studying the companies building AI-enabled defense, zero-trust architecture, endpoint security, identity protection, cloud workload defense, and public-sector compliant platforms. 

Names like Palo Alto Networks, CrowdStrike, Zscaler, SentinelOne, Fortinet, Okta, and Check Point all touch pieces of that evolving battlefield, though each does so differently and with different risk-reward profiles. 

February’s selloff shows how sharply sentiment can swing in these names, which is exactly why serious investors should do the work before the crowd rediscovers the thesis. 

The bigger point is simpler than any one ticker.

AI is not a magic wand that fixes cyber risk. It’s gasoline on the fire, but it’s also a better hose for the firefighters at the same time. 

And in a world where states, proxies, criminals, and ideological actors can all use digital tools to reach across borders, cybersecurity is no longer an optional growth category. 

It’s a critical part of the defense stack itself.

That means last month’s selloff may start looking less like insight and more like a gift, even sooner than expected.

Investors who understand that early won’t just be buying software. 

They’ll be buying exposure to the companies turning AI into a shield against the people trying to use it as a sword.

Every few years, Wall Street rediscovers a very old truth: some of the most valuable businesses in the world are built around solving the problems that matter most. 

And it’s hard to find a problem bigger than cancer.

That’s what makes oncology such an interesting hunting ground for investors. 

This isn’t just another trendy corner of biotech where everybody chases a buzzword for six months and moves on. 

The Biggest Market Nobody Can Ignore

Cancer treatment is one of the few areas where real scientific progress can create massive value, not just because the market is huge, but because the need is permanent. 

As researchers get better at identifying specific tumor markers, training the immune system, and delivering drugs more precisely, the range of possible winners keeps expanding. 

That creates a real opportunity for retail investors. 

You don’t need to be a hedge fund biotech specialist with a PhD in molecular biology to see what’s happening here. You just need to understand the basic setup…

The old model of blasting patients with broad, toxic chemotherapy is slowly giving way to more targeted approaches. 

Some of those approaches are already proving themselves commercially. 

Others are earlier and more speculative, but they’re inching closer to clinical moments that could change how the market values them overnight. 

Don’t Look for One Hero

This is where a lot of investors get themselves into trouble… 

They go hunting for one miracle stock, one tiny biotech, one glorious “I found it first” story they can brag about later. 

That sounds great in theory. In practice, it’s usually how people get wiped out by one ugly trial result, one financing round, or one regulatory delay.

The better way to approach this space is to think like a portfolio builder, not a gambler. 

Oncology is not one trade. It’s a collection of different technological bets. 

You’ve got radioligand therapies, antibody-drug conjugates, precision small molecules, immune-cell therapies, and natural killer cell engagers all pushing toward the same prize from different angles. 

The smart move is not to marry one company and pray. 

The smart move is to own a basket of serious contenders across different treatment platforms and let the eventual winners do the heavy lifting. 

That’s how I’d frame this whole opportunity…

Not as a biotech lottery ticket, but as a long-term portfolio theme. A basket of potential cancer cures. 

Some of them are safer. Some are more explosive. Some will fail. That’s part of the game. 

But if you spread your exposure intelligently, you give yourself a shot at capturing upside from one of the most important innovation cycles in the market.

The Grown-Up Money

If you want to start on the safer side, begin with the big, established players that already have real oncology businesses and real resources behind them.

Novartis is one of the clearest examples… 

Its Pluvicto franchise has made radioligand therapy one of the most compelling treatment categories in oncology, and in February 2026 the company released new real-world data reinforcing earlier use of Pluvicto before chemotherapy in metastatic castration-resistant prostate cancer. 

The company said chemo-naïve patients with PSMA-positive disease showed median progression-free survival of 13.5 months. 

That matters because when a treatment starts moving earlier in the line of care, the commercial opportunity tends to get much bigger. 

AstraZeneca belongs in that same “grown-up money” bucket… 

Its exposure to antibody-drug conjugates gives investors a seat at one of the hottest tables in cancer treatment. 

In February 2026, AstraZeneca said Datroway received Priority Review in the United States for first-line metastatic triple-negative breast cancer in patients who are not candidates for immunotherapy, based on results showing significantly improved overall survival versus chemotherapy. 

That’s a strong signal that these smarter payload-delivery systems are not just interesting science projects anymore. They’re increasingly looking like future standards of care. 

These kinds of names usually won’t give you the crazy overnight upside of a tiny small-cap biotech. But they do give you something most small biotechs don’t: durability…

You can own them without feeling like one bad headline is going to send the whole position into a crater. 

And for a lot of investors, that’s exactly where the foundation of an oncology portfolio should start.

Where Things Get Interesting

Once you move beyond the giant pharma names, the upside starts to get a lot more exciting. But it also gets a bit more hazardous…

Revolution Medicines is one of the names that stands out most to me in that category. 

The company is targeting the RAS pathway, one of the most important and historically frustrating targets in all of oncology. 

For years, these mutations were viewed as some of the hardest problems in cancer drug development. Now Revolution is pushing a late-stage pipeline aimed right at that opportunity. 

In February 2026, the company said it remained on track for a pivotal first-half 2026 readout from its Phase 3 trial in second-line metastatic pancreatic cancer, while also advancing a broader late-stage pipeline that includes five ongoing Phase 3 trials and plans for three more to start in 2026. 

That is exactly the kind of setup growth-oriented healthcare investors look for…

Big addressable market. Serious scientific rationale. A clinical catalyst with the potential to materially rerate the stock. 

This doesn’t make Revolution a sure thing. Nothing in oncology is a sure thing. But it does make it one of the more credible higher-beta names in the group.

This is the sweet spot where the market often misprices opportunity. A company is no longer a science experiment, but it still hasn’t fully earned blue-chip credibility. 

That gap between promise and acceptance is where some of the best returns can come from.

The Real “Lottery Ticket” Zone

Then you get down to the truly speculative names, and this is where GT Biopharma comes in.

This is not a conservative stock. This is not a “set it and forget it” investment. This is a nano-cap oncology speculation with all the risk that comes with that label. 

But it also has something speculative investors are always looking for: a real, near-term clinical setup tied to a differentiated approach.

GT Biopharma is developing TriKE technology, short for tri-specific killer engager, designed to harness natural killer cells against cancer. 

In February 2026, the company announced FDA clearance of its IND for GTB-5550, a targeted natural killer cell engager for solid tumors, and said a Phase 1 dose-escalation basket trial is expected to begin in mid-2026. 

That’s not fluff. That’s a meaningful milestone for a company of this size. 

But, let’s be adults about this. A tiny company with an early-stage program can absolutely produce enormous upside if the data start to line up. 

It can also dilute shareholders, stumble operationally, or disappoint in the clinic. Both things are true. 

Still, this is exactly the kind of name that can transform a portfolio when it works. You just have to size your position like a rational human.

Why The Basket Matters More Than the Story

The temptation in biotech is always to fall in love with a story…

Investors hear a slick pitch, memorize a few scientific acronyms, and start acting like they’ve found the next ten-bagger with absolute certainty. 

But oncology has a way of humbling that kind of confidence.

That’s why the basket matters more than any single narrative. You want exposure to several different types of cancer-treatment innovation at once. 

You want a few larger names with established franchises. But, you also want a few mid-sized names with strong pipelines and major upcoming catalysts. 

And then, if your risk tolerance allows it, you want a couple of small speculative shots with truly asymmetric upside.

That framework is what makes the whole idea work. 

It lets you participate in a field where one winner can create enormous value without forcing you to pretend you know exactly which company will get everything right. 

And let’s be honest, in a field as complex as cancer treatment, it’s tough to know anything with certainty until the results are in.

Build The Portfolio Before Everyone Else Does

Here’s the bottom line: Oncology is one of the richest long-term opportunity sets in the market.

The problem is massive, the science is improving, and the companies making genuine progress can become incredibly valuable. 

The market will eventually reward the businesses that prove they can extend survival, move treatments earlier in care, or open up entirely new ways of fighting tumors. 

We’re already seeing that happen in radioligands, antibody-drug conjugates, and targeted precision oncology. 

The key for retail investors is not to wait until everything feels obvious and comfortable. By then, the easy gains are usually gone. 

The key is to start building exposure now, thoughtfully and with discipline. 

Own some of the bigger names for stability. Add some mid-tier innovators for upside. Sprinkle in a few moonshots if you can stomach the volatility. 

Then let time, clinical progress, and portfolio construction do the work.

That’s the real play here. Not chasing one miracle. Building yourself a portfolio of potential cancer cures.

Don’t just watch this theme from the sidelines while Wall Street circles around the next generation of oncology winners. 

Start building your basket. Start doing the work. Start putting capital behind the companies trying to change the future of cancer treatment. 

Because if even a handful of these platforms deliver, the medical upside will be enormous, and the investment upside could be, too.

The market still talks about AI like it’s mostly a software story. 

Better models. Faster chips. Smarter applications. Bigger cloud contracts. 

All of that matters. But the deeper story now is electricity…

AI infrastructure is turning into a power business wrapped inside a technology business, and Washington knows it.

The Real AI Race

The Trump White House has spent the past year pushing an aggressively pro-build posture on both energy and AI. 

It has made clear that it wants America to dominate the next generation of digital infrastructure, but it has also made clear that ordinary households should not be forced to foot the bill for that ambition. 

That’s the key point. 

Washington is not saying slow down. It’s saying build faster, but build smarter.

And that changes the investment map in a big way… 

If data center developers can no longer just show up, plug into a stressed grid, and let rate structures absorb the pain later, then location becomes everything. 

The first big winners in this buildout are likely to be the companies that already understand one brutal truth…

The best AI site is not necessarily the one closest to the biggest city. It’s the one closest to the best power.

Power Is the Moat

Everybody wants to talk about demand, and yes, demand is enormous. But demand without deliverable electricity is just a pitch deck. 

The real bottleneck is not whether companies want more compute. Of course they do. 

The real bottleneck is whether enough reliable power can be brought online fast enough, cheaply enough, and politically cleanly enough to support that compute.

That’s where the moat starts to form. 

If you can build right beside abundant generation—or in a region where low-cost power already exists—you solve problems that other developers are still pretending aren’t there. 

You reduce grid friction. 

You shorten energization timelines. 

You make project economics easier to finance. 

And in a market where speed matters almost as much as scale, that advantage is massive.

This is why co-location has become such an important concept…

The companies that can pair massive compute demand with dedicated or advantaged supply are going to have the inside track. 

Everybody else may still get there eventually, but they’ll arrive later, spend more money getting there, and face more regulatory and political resistance along the way.

Where the Extra Power Lives

So where does this extra power actually exist? 

Start with hydroelectric regions… 

Big hydro offers stable, dispatchable electricity, and some of the best hydro corridors in North America have already been attracting power-hungry infrastructure for years. 

That’s not an accident. 

Cheap, dependable electricity tends to attract industries that care more about megawatts than zip codes.

Then there’s nuclear… 

For a long time, nuclear was treated like yesterday’s story. Today it looks a lot more like tomorrow’s backbone. 

AI workloads are relentless. They don’t want intermittent supply. They want dense, always-on power, and nuclear fits that description almost perfectly. 

A data center next to a reactor has a very different strategic profile than one sitting at the end of a crowded transmission line hoping for upgrades.

And then there’s geothermal, which may be one of the most underappreciated pieces of this entire puzzle… 

Unlike wind and solar, geothermal can run around the clock. 

Unlike large nuclear projects, it can sometimes be scaled in ways that fit regional growth more flexibly. 

Places with strong geothermal potential could become much more important to AI infrastructure than most investors currently realize.

And the market is slowly starting to understand this. 

The race isn’t just to build data centers. It’s to build them where the electrons already exist, or where they can be added with the least friction and the greatest certainty.

Nuclear Next Door

Amazon has already shown the market what this looks like in practice… 

Its move to secure data center infrastructure next to nuclear power in Pennsylvania wasn’t some random real estate decision. It was a power-first strategy hiding in plain sight.

If you’re a hyperscaler staring down years of rising AI demand, you do not want to sit around waiting to find out whether the local grid can support your next wave of expansion. 

You want direct proximity to a massive, dependable, around-the-clock source of electricity. 

You want a cleaner line of sight on supply. And you want less uncertainty. 

That’s what nuclear adjacency gives you.

Microsoft has been reading from the same playbook… 

Its support for bringing major nuclear capacity back into the conversation is one of the clearest signs that serious AI players are willing to go well beyond simply buying electricity off the grid. 

They are thinking about how to make sure the power exists in the first place.

That’s an important shift. 

The biggest AI infrastructure players are no longer acting like passive utility customers. 

They are becoming active architects of the energy systems they need. 

Investors should pay close attention when companies with essentially unlimited capital start behaving like that. 

They are telling you where the bottleneck is, and they are telling you how they plan to solve it.

Hot Rock, Cold Cash

Google has been moving down a slightly different path, but toward the same destination… 

Its geothermal efforts show how hyperscalers are trying to anchor data center growth to power sources that can run day and night without depending on the weather. 

That’s a smart strategy in any environment. In one where Washington wants AI expansion without ratepayer pain, it becomes even smarter.

Geothermal doesn’t get the same flashy headlines as nuclear restarts or giant gas plants, but it may end up being one of the quiet winners of this whole cycle. 

It offers reliability. It offers scalability in the right regions… 

And it offers a way to support major compute loads without leaning too heavily on already strained grid infrastructure.

The companies that figure this out early won’t just get cheaper electricity. 

They’ll get time. They’ll get optionality. They’ll get a smoother permitting story. They’ll get the ability to expand with fewer headaches. 

And in a market where demand is exploding and everybody wants capacity yesterday, that optionality is worth a fortune.

The Hydro Advantage

Not every winner in this story is going to be a household-name hyperscaler…

Some of the clearest beneficiaries may be the operators that spent years building in places where cheap, dependable hydro power was already available.

That’s the logic behind the long-standing data center clusters in the Pacific Northwest and other hydro-rich regions. 

These operators understood something years before the broader market started waking up to it: power matters more than glamour. 

A flashy site near a major metro might look great in a presentation, but a site sitting on top of some of the cheapest and most reliable electricity in North America is often a far better business.

Sabey is a good illustration of that logic… 

Its Columbia campus wasn’t built around hype. It was built around access to hydro. 

That’s the kind of decision that may have looked boring to some investors a few years ago. 

Today it looks like foresight. 

As the AI buildout pushes deeper into the power question, companies that already staked out hydro-rich territory may find themselves holding much more strategic assets than the market once gave them credit for.

BitZero Saw This Coming

Then there’s BitZero, which is where this story gets especially interesting for investors willing to look before the crowd fully catches on. 

BitZero is not trying to become just another generic AI infrastructure name with a big narrative and not much underneath it. 

The company has spent years assembling a global network of data center operations tied to advantaged power, especially hydroelectric power, and now it’s working to build more of that same model in the United States.

That matters because BitZero is approaching the market from the right end of the problem. 

It’s not starting with a land parcel and then hoping the electricity shows up. It’s starting with energy logic and building the compute opportunity around that. 

In a market where access to abundant power is becoming one of the core constraints, that is exactly the kind of positioning investors should be paying attention to.

A lot of small companies talk about opportunity. Far fewer have infrastructure, relationships, operating experience, and a strategy that lines up cleanly with where the market is actually headed. 

BitZero’s global network near excess hydroelectric supply gives it a head start in a world that is suddenly placing a premium on exactly that kind of footprint. 

If the market starts re-rating power-first operators as strategic AI infrastructure plays, BitZero could find itself in a much brighter spotlight.

The Early Winners

This is the part I don’t think the broader market fully appreciates yet… 

In the early phase of an infrastructure boom, investors usually chase the most visible names first. 

They buy the chip giant. They buy the most famous cloud operator. They buy the software platform everybody already knows. 

Sometimes that works. But the bigger asymmetrical gains often come from identifying the bottleneck before everyone else does.

Right now, that bottleneck is not interest in AI. Nobody needs to be convinced that AI demand is real. 

The bottleneck is power that can actually be delivered, in the right place, on the right timeline, without creating political blowback or hammering ratepayers.

That means the premium may accrue first to the companies that already built their models around that reality… 

The operators sitting near dams. The hyperscalers striking deals near nuclear assets. The developers leaning into geothermal regions. 

The smaller firms like BitZero that understood early that the future of compute would be constrained not by imagination, but by megawatts.

That does not mean every company with a “power” slide in its investor deck is a winner. 

Plenty will overpromise. Plenty will discover that transmission, permits, and execution are harder than they expected. 

But the category itself is real. The shift is real. And the companies already positioned around excess or advantaged power are likely to be the biggest initial beneficiaries.

Before the Crowd Catches On

This is one of those moments when the market is giving you a clue… 

Washington wants rapid AI expansion. It wants the United States to dominate the sector. 

But it also wants that expansion to happen without driving up electricity costs for ordinary Americans. 

That pushes the entire industry toward a smarter model, one where data center demand is paired with dedicated supply or located near regions where abundant power already exists.

That’s not background noise. That’s the thesis.

So, pay attention to the companies already sitting on power-rich ground. 

Pay attention to the operators building near hydro dams, nuclear plants, and geothermal resources. 

Pay attention to the smaller names the market has not fully re-rated yet, especially the ones that already have real infrastructure and real plans in motion.

Because once Wall Street fully realizes that the first true winners of the AI buildout are not just the firms with the best models, but the firms with the best megawatts, the easy gains won’t be easy anymore. 

Learn more now. Do the work now. And get invested before the market figures out who the real winners are and reprices them accordingly.

Hint: When sentiment overwhelms the facts, it might be time to take a closer look.

This week, a press release went out that handed the market exactly the kind of biotech story investors claim they want.

A company released new data on its experimental treatment for generalized anxiety disorder, and on the surface the readout looked compelling. 

Adults with moderate-to-severe anxiety, despite already taking standard antidepressants, received just two injections spaced three weeks apart. 

Layered on top of existing medication, the higher-dose regimen produced a double-digit reduction on a major anxiety scale by week six. 

Better yet, the benefit appeared durable out to six months. No serious drug-related side effects were reported.

For a patient population that has often already cycled through SSRIs, SNRIs, and the rest of psychiatry’s usual toolbox, this treatment looked less like an interesting lab experiment and more like a potentially meaningful new option.

And yet the stock got crushed.

On the same day the company shared the data, its shares fell roughly a third on heavy volume.

That kind of move tends to trigger one immediate conclusion: something must be wrong.

But that conclusion may be too simple. 

Because when you look past the shock of the one-day decline and examine the setup into the event, a different interpretation starts to emerge. 

In the days before the announcement, the company — Helus Pharma (NASDAQ: HELP) had already staged a sharp speculative run into the $8-plus area, a zone that has repeatedly acted as resistance over the past year. 

The stock ran hard into the catalyst press release.

It hit a known resistance area, then snapped back toward a well-established support band. 

But that does not automatically suggest a broken story. 

It may simply suggest a crowded trade unwinding.

Because many traders in small-caps like Helus Pharma (NASDAQ: HELP) are not buying with a five-year horizon. They are buying because there is a date on the calendar. They want anticipation. They want momentum. They want a catalyst pop.

So they load up days or weeks before the event, ride the run, and often sell into the release no matter what the data says.

If those traders bought in the upper $5s and watched the stock rip into the $8s ahead of the announcement, then a positive readout was not necessarily a reason to hold … It was a liquidity event. 

In other words, the market’s message may not have been, “The science failed.”

It may have been, “The trade worked.”

That is a very different thing.

And the actual content of Helus’s release leans in that direction.

So, clearing away the market noise, what does the release actually say?

The company reported statistically significant efficacy. 

It showed roughly a 10-point improvement on a validated anxiety measure. It demonstrated durability out to six months. 

It reported clean tolerability, with no serious drug-related adverse events and no suicide-related safety signals flagged.

Objectively, that is the kind of dataset many development-stage biotechs would be thrilled to own.

But markets do not reward news in a vacuum. They reward news relative to expectations.

And expectations, especially in small-cap biotech, rarely stay grounded for long.

And once that sentiment shifted, other familiar small-cap forces likely added fuel to the decline.

The float is limited. Retail participation is high. That means emotion travels fast.

Once the stock lost the $7 area, stop-loss selling likely kicked in. That kind of forced selling can turn a retreat into a rout. Add in a shareholder base full of event-driven traders, and suddenly the exit door gets crowded fast.

That does not mean the business deteriorated overnight.

It means traders saw a reason to protect gains while liquidity was available.

The real question is whether anything in the actual data release meaningfully damaged the long-term thesis.

Did HLP004 suddenly stop looking relevant for treatment-resistant anxiety?

Did the company reveal a new safety concern that changes the risk-reward equation?

Did the efficacy signal come in weak or ambiguous?

So far, the answer appears to be no.

The signal still looks meaningful. The durability remains notable, especially for such a light-touch dosing schedule. And the safety profile, at least in this early cohort, appears manageable.

If the underlying probabilities have not changed much, then what investors may be watching now is not a collapse in fundamentals but a washout in sentiment.

And those are not the same thing.

In fact, the best “buy the dip” opportunities often show up precisely when the market confuses the two.

A failed trial is not a dip to buy.

A new safety problem is not a dip to buy.

A regulatory setback is not a dip to buy.

But a stock that gets hit because traders had already front-run the news, because expectations became inflated, because stop-losses cascaded, and because dilution anxiety spiked?

That can be very different.

That can be the kind of mess long-side investors learn to study instead of fear.

If Helus Pharma (NASDAQ: HELP) can stabilize around its historical support band in the mid-$5s and start reclaiming the low-$6s, the selloff will increasingly look like what it probably was: a fast-money reset after an overextended catalyst run.

But as of now, the broader story still looks intact.

HLP004 still represents a notably different treatment model in anxiety: two closely supervised clinic visits instead of years of daily pill burden. A short period of intense psychoactive intervention followed, in some patients, by months of relief. A setup that could fit neatly into the growing ecosystem of clinic-based mental-health care, particularly for severe patients where payers have already shown a willingness to reimburse more intensive treatment models.

Helus also still has a related depression program built around the same short-course, durable-reset philosophy.

And it still operates in a large, underserved market filled with patients who do not feel well-served by conventional options.

Helus may be one of those cases where the market is simply emotional, crowded, impatient, and allergic to anything that falls short of fantasy.

And if it is, then this week’s plunge may ultimately be remembered not as the moment the story broke, but as the moment sentiment temporarily buried the fundamentals.

That is often where the best dip-buying opportunities begin.

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of Helus Pharma (NASDAQ: HELP). Rebel Investors Club is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities. In an effort to enhance public awareness, Helus Pharma (NASDAQ: HELP) provided advertising agencies with a total budget of approximately $2,914,712 and is the sole source of funds to cover the costs associated with creating, printing and distribution of this advertisement.  From that total budget, Moneta Advisory Partners, an affiliate of Rebel Investors Club was paid $500,000 as a research fee and for the production and placement of additional advertising media for this campaign. The advertising agencies will retain any excess sums after all expenses are paid. Rebel Investors Club may receive subscription revenue in the future from new subscribers as a result of this advertisement for its newsletter.

While this advertisement is being disseminated and for a period of not less than 90 days thereafter, Rebel Investors Club , the advertising agencies, and their respective officers, principals, or affiliates will not sell securities of Helus Pharma (NASDAQ: HELP). If successful, this advertisement will increase investor and market awareness of Helus Pharma (NASDAQ: HELP) and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, the advertising agencies and Rebel Investors Club do not purport to provide a complete analysis of Helus Pharma (NASDAQ: HELP) or its financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. 

This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about Helus Pharma (NASDAQ: HELP). Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in Helus Pharma (NASDAQ: HELP) SEC filings. Investing in microcap securities such as Helus Pharma (NASDAQ: HELP) is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Rebel Investors Club cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. 

This advertisement contains forward-looking statements, including statements regarding expected continual growth of Helus Pharma (NASDAQ: HELP) and/or its industry. The advertising agencies and Rebel Investors Club note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect Helus Pharma (NASDAQ: HELP) actual results of operations. Factors that could cause actual results to vary include the size and growth of the market for Helus Pharma (NASDAQ: HELP) products and/or services, the company’s ability to fund its capital requirements in the near term and long term, federal and state regulatory issues, pricing pressures, etc. 

Rebel Investors Club is the publisher’s trademark. All trademarks used in this advertisement other than Rebel Investors Club are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Rebel Investors Club are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks. 

This past weekend’s confrontation involving the United States and Israel wasn’t just another chapter in modern conflict. It was a preview…

Yes, there were aircraft, missiles, drones, and explosions — the things war has always relied on to send a message. 

But beneath the surface, running in parallel, was something far more consequential…

When the First Strike Isn’t a Bomb, It’s a Line of Code

A digitally coordinated campaign where cyber operations and artificial intelligence worked hand-in-hand with physical force.

That’s the part most headlines glossed over. And it’s the part investors need to understand.

Because the future of warfare isn’t tanks or keyboards. It’s both. Simultaneously. Integrated. Relentless.

And if that’s how wars are fought, then defending digital infrastructure is no longer an IT expense. It’s a national security imperative.

Modern War No Longer Begins at the Border

Traditional war had a starting line. Troops crossed borders. Aircraft crossed airspace. Naval fleets crossed horizons.

Digital war has no such courtesy… 

By the time the first missile launches, the real work is often already done. 

Networks have been probed. Systems mapped. Communications degraded. Confusion seeded. Decision-makers delayed. Data corrupted. Signals distorted.

And what unfolded over the past weekend followed a pattern military planners have been perfecting for years: weaken the digital nervous system first, then strike the physical body.

AI now accelerates that process beyond anything humans could manage alone. 

It ingests vast streams of intelligence, detects vulnerabilities in real time, and helps planners model cascading effects — not just on targets, but on responses.

This isn’t science fiction. It’s simply what happens when computing power collides with geopolitics.

The Fusion of AI and Cyberwarfare Changes Everything

Cyberwarfare used to be disruptive. Annoying. Sometimes destructive.

AI turns it into something else entirely.

Artificial intelligence allows attackers — and defenders — to operate at machine speed. 

Networks can be scanned continuously. Threats classified instantly. Countermeasures deployed automatically. False signals identified. Anomalies flagged before humans even notice something is wrong.

In a battlefield environment, this means physical strikes are no longer isolated events… 

They are synchronized moments in a much larger system — one where digital pressure shapes physical outcomes.

Disable communications at the right moment and air defenses hesitate. 

Corrupt logistics data and resupply slows. 

Confuse command systems and response times stretch just long enough for kinetic strikes to land cleanly.

This is digital warfare as a force multiplier.

And once that threshold is crossed, there’s no going back.

America’s Real Vulnerability Isn’t Missiles — It’s Infrastructure

Here’s where investors need to lean forward…

The United States doesn’t need to worry most about tanks rolling across borders. 

It needs to worry about attacks on power grids, financial networks, telecommunications systems, transportation hubs, water systems, and data centers.

Those are the arteries of modern society.

They are also digital.

The same techniques used overseas — AI-driven intrusion detection, automated network disruption, signal manipulation — can be turned inward by adversaries who understand that paralyzing infrastructure is often more effective than direct military confrontation.

The uncomfortable truth is this: America’s greatest strength — its technological integration — is also its greatest exposure.

And defending that exposure at scale is impossible without artificial intelligence.

Cybersecurity Is No Longer a Software Category — It’s a Defense Sector

For years, cybersecurity was treated like plumbing… 

Necessary, invisible, unexciting. A line item, not a strategy.

But that era is over.

AI-powered cybersecurity is now part of the national defense stack. Just as radar defined air defense in the 20th century, intelligent cyber defense defines security in the 21st.

Why? Because human analysts simply can’t respond fast enough. 

They can’t monitor millions of endpoints simultaneously. They can’t anticipate novel attack patterns without machine learning models trained on oceans of data.

AI doesn’t just defend against known threats…

It identifies unknown ones — the zero-day exploits, the behavioral anomalies, the subtle deviations that signal something is wrong before damage spreads.

That capability isn’t a luxury. It’s table stakes.

The Military Lesson Investors Shouldn’t Ignore

Wars have always accelerated technological adoption…

Radar. Jet engines. Satellites. Nuclear power. GPS. The internet itself.

What we’re seeing now is the militarization of AI-driven cybersecurity — and once that happens, civilian adoption follows fast.

Defense budgets don’t fund experiments. They fund deployment.

When governments begin integrating AI cyber tools into military doctrine, those same technologies quickly find their way into energy systems, financial institutions, healthcare networks, and industrial operations.

The implication is simple: cybersecurity companies that can operate at machine speed, at national scale, and under hostile conditions are no longer niche tech plays. 

They are strategic assets.

And strategic assets tend to get funded, contracted, and prioritized — regardless of economic cycles.

The Quiet Arms Race Happening Behind the Screens

There’s an arms race underway that never appears on missile-count charts.

It’s measured in model accuracy, response latency, detection rates, false positives avoided, and automated containment success.

Adversaries aren’t just building weapons…

They’re building algorithms. They’re training systems to evade detection, mimic normal behavior, and exploit trust relationships between machines.

Defending against that requires systems that learn faster than attackers can adapt.

This is why AI is not an add-on to cybersecurity anymore. It’s the core.

And it’s why the winners in this space won’t necessarily be the loudest brands — they’ll be the ones embedded deep inside critical systems, invisible until something tries to break them.

From Battlefield to Balance Sheet

Investors often ask me how to spot long-term themes before Wall Street fully prices them in.

Here’s one: the convergence of AI, cybersecurity, and national defense.

It’s not cyclical. It’s structural.

Geopolitical instability doesn’t reduce digital risk — it multiplies it. 

Every conflict increases the incentive to probe, disrupt, and exploit digital systems far beyond the physical battlefield.

That means spending doesn’t retreat when wars end. It expands.

Budgets shift from reactive defense to continuous monitoring…

From static firewalls to adaptive intelligence… 

From human-centered workflows to autonomous response systems.

And once those systems are in place, ripping them out isn’t an option.

Why This Moment Matters More Than Headlines Suggest

What happened this weekend wasn’t just a tactical operation. It was a signal…

It said: future conflicts will be fought across networks as much as across terrain. 

Victory will depend as much on algorithms as on aircraft. And resilience will matter more than raw firepower.

For investors, this reframes cybersecurity entirely.

You’re no longer investing in protection from hackers. You’re investing in the digital immune system of nations.

That’s a much bigger idea.

And historically, when markets finally understand ideas like that, valuations follow.

The New Reality: Digital Defense Is National Defense

The most important takeaway isn’t which systems were used, or which tools were deployed, or which models ran in the background.

It’s that the line between cyber and kinetic warfare is gone.

Digital attacks now shape physical outcomes. Physical strikes rely on digital dominance. And artificial intelligence is the glue binding them together.

For the United States, defending digital infrastructure is no longer a secondary concern. It is the frontline.

For investors, understanding that shift — early — is how you position ahead of one of the most durable, government-backed, mission-critical investment themes of the next decade.

The invisible front is here. And it’s not going away.

Stay alert. Stay early. Stay positioned.

The strategic narrative around space just shifted again. 

During a February 23, 2026 stop in Denver as part of the Department of War’s “Arsenal of Freedom” tour, Secretary of War Pete Hegseth declared space “the ultimate high ground — the single most decisive battlefield of this century.” 

That message comes as Congress has already approved $839 billion in defense spending for fiscal 2026, including billions earmarked for missile warning, tracking satellites, and integrated space and missile defense systems. 

Public companies operating at the intersection of commercial launch and national security — including Starfighters Space (NYSE-A: FJET), Rocket Lab (NASDAQ: RKLB), L3Harris Technologies (NYSE: LHX), Intuitive Machines (NASDAQ: LUNR), and Northrop Grumman (NYSE: NOC) — are increasingly positioned at the center of that shift.

The War Department’s remarks in Colorado underscored an urgency to broaden the defense industrial base beyond traditional primes. Speaking to workers at commercial space companies, Hegseth emphasized the need to “open the aperture” and accelerate innovation, stating, “Whoever controls space, controls the future fight; it’s that simple.” For investors, that messaging reinforces a structural theme: national security is driving sustained demand for launch capacity, resilient satellite constellations, hypersonic testing, and missile tracking infrastructure.

Starfighters Space (NYSE-A: FJET) is one of the smaller, newly public entrants aligned with this trend. 

Based at NASA’s Kennedy Space Center, the company operates modified supersonic aircraft designed to serve as first-stage air-launch platforms under its STARLAUNCH system. Recently, the company completed subsonic and supersonic wind tunnel testing for STARLAUNCH 1 at Mach 0.85 and Mach 1.3, validating clean separation behavior across flight regimes and correlating results with its computational models. 

The company also initiated procurement of an instrumented demonstrator vehicle for underwing flight testing and is preparing for a Critical Design Review. “As we move into the commercialization era of our business, we are grateful for the strong foundation, both operationally and financially, [founder Rick Svetkoff] has left us,” said CEO Tim Franta, following his appointment after the company’s NYSE listing. 

The milestone testing and leadership transition signal a shift from concept validation toward execution and commercialization.

Rocket Lab (NASDAQ: RKLB) continues to expand its role in national security space. 

The company is preparing to launch its Cassowary Vex mission using its HASTE rocket platform for the Department of War’s Defense Innovation Unit. 

The mission will deploy a scramjet-powered test vehicle developed by Hypersonix, marking the company’s fourth hypersonic test launch in under six months. 

Rocket Lab also holds more than $1.3 billion in contracts from the Space Development Agency (SDA), including an $816 million award to build 18 missile defense satellites equipped with next-generation infrared sensors for the Tracking Layer Tranche 3 program. 

The company has stated that its vertically integrated model enables faster delivery and lower costs — a structure that aligns with the War Department’s call for speed and execution in strengthening the industrial base.

L3Harris Technologies (NYSE: LHX) recently reorganized its business from four segments to three, creating a dedicated Space & Mission Systems unit following an $843 million SDA contract to build 18 infrared satellites for Tracking Layer Tranche 3. 

The restructuring consolidates missile warning, missile defense, and space payload capabilities under a unified structure. “This change thoughtfully organizes common business models, technical capabilities and investment priorities,” said Chairman and CEO Christopher Kubasik. The company currently has four missile tracking satellites on orbit for Tranche 0 and dozens more in development, reinforcing its role in proliferated space architecture.

Intuitive Machines (NASDAQ: LUNR) completed its $800 million acquisition of Lanteris Space Systems (formerly Maxar Space Systems), combining $450 million in cash and $350 million in stock. 

The deal expands the company into vertically integrated spacecraft manufacturing and strengthens its ability to compete for SDA and NASA programs. “This acquisition marks a defining moment in the evolution of Intuitive Machines,” said CEO Steve Altemus. “We previously proved our ability to operate on the Moon. With Lanteris, we add flight-proven manufacturing at scale.” 

The combined entity reports over $850 million in revenue and approximately $920 million in backlog, positioning it for broader participation in national security and lunar initiatives.

Northrop Grumman (NYSE: NOC) was selected as one of four prime contractors under the SDA’s $3.5 billion Tranche 3 Tracking Layer program. 

The company is responsible for a significant portion of the 150 satellites planned across the first three tranches of the Proliferated Warfighter Space Architecture. “Northrop Grumman’s contributions to both high and low altitude layers of our nation’s missile warning and tracking architecture help protect our nation from a wide range of threats,” said Brandon White, Vice President of Space-Enabled Multi-Domain Operations. 

The company projects its Space Systems segment to reach approximately $11 billion in fiscal 2026, reflecting increasing demand for missile warning and space-based sensing.

While larger primes and established launch providers command substantial contracts, Starfighters Space (NYSE-A: FJET) represents an earlier-stage entrant that directly aligns with the War Department’s message about expanding the competitive field. 

As Hegseth emphasized in Denver, “We can’t just rely on the big [defense contractors]… We have to open the aperture and ensure that scrappy companies that have great ideas… are able to compete on a level playing field.” 

For smaller, specialized launch companies, that policy tone could translate into increased testing, prototyping, and niche mission opportunities.

Starfighters’ differentiator centers on its air-launch model. 

The company states it is the only commercial operator capable of sustained Mach 2 flight for payload carriage, enabling rockets to be deployed from approximately 45,000 feet. This approach can offer flexibility in launch azimuth, weather avoidance, and rapid mission scheduling compared to fixed-pad systems. 

Recent wind tunnel validation at both subsonic and supersonic speeds reduces aerodynamic risk ahead of fabrication and integration. The upcoming Critical Design Review supported by GE Aerospace represents a formal engineering milestone before advancing to hardware production.

In terms of operational traction, Starfighters has increased visibility following its public listing and rang the Opening Bell at the New York Stock Exchange. 

Leadership continuity also appears to be a focus. Former Congressman Bill Posey, who represented Florida’s Space Coast for over a decade, endorsed the CEO transition, stating, “It is very fitting that [Franta] now leads a company that aims to continue that development.” Franta himself brings more than two decades of experience in space commercialization, including roles tied to FAA licensing and infrastructure funding in Florida.

From a competitive standpoint, air-launch systems face high technical and regulatory barriers. Integration with supersonic aircraft, FAA launch licensing, propulsion validation, and aerodynamic separation testing all represent specialized engineering domains. 

Starfighters’ proximity to Kennedy Space Center and its experience operating modified supersonic aircraft provide a foundation that may be difficult for new entrants to replicate quickly. 

As missile defense architectures increasingly require responsive launch and testing capabilities, flexibility and speed could become strategic advantages.

Looking ahead, near-term catalysts for Starfighters include completion of its Critical Design Review, progression into fabrication and integration of STARLAUNCH 1, and further underwing flight testing of its instrumented demonstrator vehicle. 

Broader sector catalysts include continued Space Development Agency tranche awards, hypersonic test demand, and execution of recently funded defense budgets emphasizing space dominance.

The macro thesis remains clear: national security priorities are accelerating investment in launch, tracking, and resilient space infrastructure. Rocket Lab, L3Harris, Intuitive Machines, and Northrop Grumman each represent scaled platforms benefiting from defined contract backlogs. 

Starfighters Space, while earlier in its commercialization arc, is positioning itself within that same structural shift — one increasingly reinforced by explicit policy messaging from the highest levels of defense leadership.

 Disclaimer: This is a paid marketing advertisement for informational purposes only and should not be construed as personalized investment advice. The Investment Journal is not a registered broker-dealer or investment advisor and is published on behalf of Creative Direct Marketing Group (“CDMG”), which is affiliated with The Investment Journal for advertising and investor awareness services. CDMG may also be compensated by the featured company or other third parties, creating a material conflict of interest. Third parties, including company insiders or shareholders, as well as The Investment Journal and its affiliates, may buy or sell securities of the featured company at any time without notice, which may impact the market price. Information presented is believed to be reliable but is not guaranteed as to accuracy or completeness, and forward-looking statements involve risks and uncertainties. Investing in securities involves substantial risk, including the possible loss of principal. Conduct your own due diligence and consult a licensed financial professional before making any investment decision. 

SOURCES:

1.) Company press releases and filings from Starfighters Space, Rocket Lab, L3Harris Technologies, Intuitive Machines, and Northrop Grumman (2025–2026).

2.) Department of War, “Hegseth, Arsenal of Freedom Tour Look to Space From ‘Mile High City’,” Feb. 23, 2026.

3.) Air & Space Forces Magazine, “Congress Passes $839 Billion Budget for Defense.”

Every bull market needs a good panic. And every panic needs a good story.

Right now, the story hitting cybersecurity stocks goes something like this.. 

“AI is going to replace traditional cybersecurity tools, make entire business models obsolete, and permanently shrink the opportunity.”

So, investors sell first and ask questions later.

Share prices fall. Valuations compress. Headlines scream disruption. 

And suddenly a sector that was “mission-critical” six months ago is being treated like yesterday’s antivirus CD-ROM.

I’ve seen this movie before. 

And spoiler alert: it usually ends with patient investors getting paid.

Because the truth is much less dramatic — and far more bullish…

The recent selloff in cybersecurity stocks isn’t a reflection of collapsing fundamentals. 

It’s a fear-driven valuation reset based on a misunderstanding of how AI actually changes the security landscape. 

In reality, artificial intelligence doesn’t reduce the need for cybersecurity. It supercharges it.

And that’s exactly why this dip deserves a closer look…


The Fear: “AI Makes Cybersecurity Obsolete”

Markets are great at two things: extrapolating trends and overreacting to them.

AI is the hottest trend on the planet right now… 

So investors naturally ask: If AI can write code, detect anomalies, and automate responses, why do we need legacy cybersecurity vendors at all?

Layer on a few breathless think-pieces about autonomous AI agents defending networks on their own, and suddenly you have a neat narrative…

Traditional cybersecurity tools are outdated, margins are at risk, and growth is about to slow.

That narrative is powerful… And also deeply flawed.

It assumes cybersecurity is a static problem that AI solves once and forever. But, in reality, cybersecurity is an arms race. 

And we all know that AI doesn’t end arms races… it accelerates them.


The Reality: AI Is Fuel for the Cyber Arms Race

Here’s the part the market is glossing over: AI empowers attackers just as much as defenders — often more.

Malicious actors are already using AI to:

• Generate polymorphic malware that constantly changes its signature
• Launch hyper-personalized phishing attacks at massive scale
• Probe networks faster and more intelligently than any human team could
• Automate vulnerability discovery across vast digital surfaces

AI doesn’t reduce threats. It multiplies them.

Every new AI model deployed inside a company becomes another attack surface. 

Every automated workflow creates new vulnerabilities. 

Every connected device and API endpoint expands the blast radius.

The result? The complexity of securing digital infrastructure explodes.

That’s not bad news for cybersecurity companies. That’s oxygen.


Why “Traditional” Cybersecurity Isn’t Going Away

Another mistake embedded in the selloff is the idea that cybersecurity companies are standing still.

But they’re not…

The best firms in this space are aggressively integrating AI into their platforms — not as a replacement, but as a force multiplier. 

AI-driven threat detection, behavioral analytics, automated response systems, and predictive modeling are becoming standard features, not optional upgrades.

This isn’t a disruption story. It’s an evolution story.

Firewalls didn’t disappear when cloud computing arrived — they adapted. 

Endpoint security didn’t vanish when mobile devices exploded — it expanded. 

And cybersecurity won’t fade because AI exists — it will embed AI at its core.

In fact, companies that don’t incorporate AI into their defenses are the ones at risk. 

The leaders are already doing the opposite: using AI to spot threats faster, respond smarter, and scale protection across environments humans can’t manually monitor.

That’s why the idea of “obsolete cybersecurity” misses the mark entirely.


The Market’s Short-Term Vision Problem

Markets love clean, linear stories. AI breaks old models, therefore old companies lose. 

Simple. Elegant. Wrong.

What we’re actually seeing is a classic short-term valuation reset driven by uncertainty, not a long-term impairment of demand.

Investors hate ambiguity more than bad news. And AI introduces ambiguity by changing how value is delivered, not whether value exists.

Cybersecurity spending isn’t discretionary. It’s not a “nice to have.” 

It’s closer to rent, electricity, and insurance. Companies don’t decide to “pause security” because the tech landscape got more dangerous. They spend more.

That’s especially true as:

• AI workloads concentrate valuable data
• Regulations tighten around data protection
• Nation-state cyber activity escalates
• Critical infrastructure becomes increasingly digital

None of these trends point to lower cybersecurity demand. Instead, they point to sustained, structural growth.


Why This Selloff Looks Like Opportunity

When great long-term businesses go on sale for short-term reasons, that’s when the math starts working in your favor.

Compressed valuations mean:

  • Lower expectations baked into prices
  • More upside if growth merely continues
  • Less downside if fear proves overblown

We’ve seen this pattern across multiple cycles…

A new technology scares investors. Stocks overshoot to the downside. Fundamentals quietly keep improving. Then the market wakes up.

Cybersecurity today feels a lot like cloud infrastructure stocks did during past “growth scares.” 

Same panic, same misunderstanding, same opportunity for investors willing to think past the next quarter.


What to Look for in Cybersecurity Winners

This isn’t about buying everything with “cyber” in the name. It’s about being selective.

The companies best positioned coming out of this reset tend to share a few traits:

• Deep integration of AI and machine learning into core products
• Large, diversified customer bases across enterprise and government
• Recurring revenue models with high switching costs
• Platforms that scale across cloud, endpoint, network, and identity

In other words, businesses that understand cybersecurity as a living system — not a static toolset.

Those are the firms turning today’s fear into tomorrow’s moat.


Fear Creates Discounts — Courage Creates Returns

I’ll leave you with this…

Every time markets panic over technological change, they assume replacement instead of reinforcement. 

But the biggest winners usually aren’t wiped out — they adapt, absorb the new tech, and emerge stronger.

AI doesn’t make cybersecurity irrelevant. It makes it indispensable.

The current selloff isn’t telling you the future is bleak. It’s telling you investors are scared. 

And fear, when divorced from fundamentals, is where opportunity lives.

This is one of those moments.

If you want to beat the market, you can’t think like the market. You have to be willing to step in when others are stepping away — to buy when headlines are loud and prices are quiet…

To be bold when others are fearful.

That’s not just a slogan. It’s how real outperformance is made.